Reach R&D directors, regulatory affairs managers, business development leads, and device procurement decision-makers at US biotech and medical device companies. Our segment covers diagnostics-adjacent biotech, IVD device manufacturers, and life science tool companies.
The US biotechnology and medical devices sector is the world's largest, with over 6,500 biotech companies and 12,000 medical device manufacturers. The diagnostics-adjacent segment — including IVD device makers, life science tools, and research reagent companies — represents a $45B+ addressable market. Key growth areas include liquid biopsy, companion diagnostics, and next-generation sequencing platforms.
Access verified contacts across all 8 specialized lab verticals.